Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer's disease?

S Mirkin, BC Albensi - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that affects memory,
thinking, behavior, and other cognitive functions. Although there is no cure, detecting AD …

Sleep duration and executive function in adults

A Sen, XY Tai - Current Neurology and Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review To review the literature examining the relationship between
sleep and cognition, specifically examining the sub-domain of executive function. We …

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer's disease

M Inglese, N Patel, K Linton-Reid, F Loreto… - Communications …, 2022 - nature.com
Background Alzheimer's disease, the most common cause of dementia, causes a
progressive and irreversible deterioration of cognition that can sometimes be difficult to …

A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic …

IS van Maurik, HM Broulikova, A Mank… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction We aim to study the effect of a more precise diagnosis, by means of amyloid
positron emission tomography (PET), on institutionalization, mortality, and health‐care costs …

[HTML][HTML] PET agents in dementia: an overview

A van Waarde, S Marcolini, PP De Deyn… - Seminars in nuclear …, 2021 - Elsevier
This article presents an overview of imaging agents for PET that have been applied for
research and diagnostic purposes in patients affected by dementia. Classified by the target …

Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort

F Loreto, A Gontsarova, G Scott, N Patel… - Annals of clinical …, 2023 - Wiley Online Library
Objectives Visual rating scales (VRS) are the quantification method closest to the approach
used in routine clinical practice to assess brain atrophy. Previous studies have suggested …

Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia

PY Chiu, FC Yang, MJ Chiu, WC Lin, CH Lu… - Scientific Reports, 2022 - nature.com
Amyloid plaques and tau tangles are pathological hallmarks of Alzheimer's disease (AD).
Parkinson's disease (PD) results from the accumulation of α-synuclein. TAR DNA-binding …

The potential of a stratified approach to drug repurposing in Alzheimer's disease

C Anderson, M Bucholc, PL McClean, SD Zhang - Biomolecules, 2023 - mdpi.com
Alzheimer's disease (AD) is a complex neurodegenerative condition that is characterized by
the build-up of amyloid-beta plaques and neurofibrillary tangles. While multiple theories …

Magnetic resonance elastography of the ageing brain in normal and demented populations: A systematic review

A Coelho, N Sousa - Human Brain Mapping, 2022 - Wiley Online Library
The aim of this systematic review was to evaluate the ability of magnetic resonance
elastography (MRE) to identify significant changes in brain mechanical properties during …

[HTML][HTML] Optimization-derived blood input function using a kernel method and its evaluation with total-body PET for brain parametric imaging

Y Zhu, Q Tran, Y Wang, RD Badawi, SR Cherry, J Qi… - Neuroimage, 2024 - Elsevier
Dynamic PET allows quantification of physiological parameters through tracer kinetic
modeling. For dynamic imaging of brain or head and neck cancer on conventional PET …